These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8062954)

  • 1. Should gonadotropin-releasing hormone down-regulation therapy be routine in in vitro fertilization?
    Harrison RF; Kondaveeti U; Barry-Kinsella C; Gordon A; Drudy L; Cottell E; Hennelly B; Frankish A; Unwin A
    Fertil Steril; 1994 Sep; 62(3):568-73. PubMed ID: 8062954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term utilization of a gonadotropin-releasing hormone agonist (buserelin) for induction of ovulation in an in vitro fertilization program.
    Loumaye E; de Cooman S; Anoma M; Psalti I; Depreester S; Schmit M; Thomas K
    Ann N Y Acad Sci; 1988; 541():96-102. PubMed ID: 3143299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian hyperstimulation for in vitro fertilization preceded by prolonged administration of a gonadotropin-releasing hormone agonist.
    Tanbo T; Dale PO; Abyholm T
    Acta Obstet Gynecol Scand; 1990; 69(4):333-7. PubMed ID: 2123069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled study of luteinizing hormone-releasing hormone agonist (buserelin) for the induction of folliculogenesis before in vitro fertilization.
    MacLachlan V; Besanko M; O'Shea F; Wade H; Wood C; Trounson A; Healy DL
    N Engl J Med; 1989 May; 320(19):1233-7. PubMed ID: 2496310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midluteal buserelin is superior to early follicular phase buserelin in combined gonadotropin-releasing hormone analog and gonadotropin stimulation in in vitro fertilization.
    Urbancsek J; Witthaus E
    Fertil Steril; 1996 May; 65(5):966-71. PubMed ID: 8612858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term luteinizing hormone-releasing hormone agonist treatment: prospective trial of a novel ovarian stimulation regimen for in vitro fertilization.
    Macnamee MC; Howles CM; Edwards RG; Taylor PJ; Elder KT
    Fertil Steril; 1989 Aug; 52(2):264-9. PubMed ID: 2502441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of buserelin acetate in an in vitro fertilization program: a comparison with classical clomiphene citrate-human menopausal gonadotropin treatment.
    Lejeune B; Barlow P; Puissant F; Delvigne A; Vanrysselberge M; Leroy F
    Fertil Steril; 1990 Sep; 54(3):475-81. PubMed ID: 2118860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The routine use of gonadotropin-releasing hormone agonists for all patients undergoing in vitro fertilization. Is there any medical advantage? A prospective randomized study.
    Kingsland C; Tan SL; Bickerton N; Mason B; Campbell S
    Fertil Steril; 1992 Apr; 57(4):804-9. PubMed ID: 1555691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro fertilization with low-dose clomiphene citrate stimulation in women who respond poorly to superovulation.
    Awonuga AO; Nabi A
    J Assist Reprod Genet; 1997 Oct; 14(9):503-7. PubMed ID: 9401867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The beneficial effects of short-term administration of a LHRH agonist (buserelin) in in vitro fertilization].
    Loumaye E; de Cooman S; Psalti I; Schrurs B; Adam T; Depreester S; Thomas K
    J Gynecol Obstet Biol Reprod (Paris); 1988; 17(8):1081-7. PubMed ID: 3148649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of an GnRH analogue for induction of gonadotrophin ovulatory surge in cycles stimulated with clomiphene citrate and menopausal gonadotropin in an in vitro fertilization program].
    Wołczyński S; Kulikowski M; Syrewicz M; Kuczyński W; Grochowski D; Sola E; Szamatowicz M
    Ginekol Pol; 1994 Oct; 65(10):573-7. PubMed ID: 7729718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ovulation induction by endogenous LH released by the administration of an LHRH agonist after follicular stimulation for in vitro fertilization].
    Emperaire JC; Ruffié A; Audebert AJ
    J Gynecol Obstet Biol Reprod (Paris); 1992; 21(5):489-94. PubMed ID: 1401761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A controlled study of gonadotropin-releasing hormone agonist (buserelin acetate) for folliculogenesis in routine in vitro fertilization patients.
    Polson DW; MacLachlan V; Krapez JA; Wood C; Healy DL
    Fertil Steril; 1991 Sep; 56(3):509-14. PubMed ID: 1909978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative trial of luteinizing hormone-releasing hormone analog/human menopausal gonadotropin and clomiphene citrate/human menopausal gonadotropin in an assisted conception program.
    Abdalla HI; Ahuja KK; Leonard T; Morris NN; Honour JW; Jacobs HS
    Fertil Steril; 1990 Mar; 53(3):473-8. PubMed ID: 2106453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of a short regimen of buserelin, a gonadotrophin-releasing hormone agonist, and human menopausal gonadotrophin in assisted conception cycles.
    Owen EJ; Davies MC; Kingsland CR; Jacobs HS; Mason BA
    Hum Reprod; 1989 Oct; 4(7):749-53. PubMed ID: 2514192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro fertilization for women with pure tubal occlusion: the impact of short gonadotropin-releasing hormone agonist treatment.
    Luxman D; Cohen JR; Lessing JB; Yovel I; David MP; Ami A
    Fertil Steril; 1995 Feb; 63(2):357-60. PubMed ID: 7843443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-finding study of triptorelin acetate for prevention of a premature LH surge in IVF: a prospective, randomized, double-blind, placebo-controlled study.
    Janssens RM; Lambalk CB; Vermeiden JP; Schats R; Bernards JM; Rekers-Mombarg LT; Schoemaker J
    Hum Reprod; 2000 Nov; 15(11):2333-40. PubMed ID: 11056128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does prolonged pituitary down-regulation with gonadotropin-releasing hormone agonist improve the live-birth rate in in vitro fertilization treatment?
    Ren J; Sha A; Han D; Li P; Geng J; Ma C
    Fertil Steril; 2014 Jul; 102(1):75-81. PubMed ID: 24746740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic value of preovulatory elevations of plasma progesterone during in vitro fertilization using LHRH agonists in a long protocol].
    Antoine JM; Firmin C; Salat-Baroux J; Alvarez S; Cornet D; Mandelbaum J; Plachot M
    J Gynecol Obstet Biol Reprod (Paris); 1992; 21(6):629-34. PubMed ID: 1430908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective randomized single-blind comparative trial of nafarelin acetate with buserelin in long-protocol gonadotrophin-releasing hormone analogue controlled in-vitro fertilization cycles.
    Lockwood GM; Pinkerton SM; Barlow DH
    Hum Reprod; 1995 Feb; 10(2):293-8. PubMed ID: 7769051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.